Patient Characteristics
| Characteristic | Value |
| No. of patients included | 73 |
| Median age (y) | 69 |
| ≥75 y old | 29 |
| ECOG score of 0 or 1 | 82 |
| ECOG score of ≥2 | 18 |
| Median PSA level (ng/mL) | 57.2 |
| Median alkaline phosphatase level (IU/L) | 154 |
| Alkaline phosphatase level of >220 IU/L | 27 |
| Median hemoglobin level (g/dL) | 11.7 |
| Hemoglobin level of ≤10 g/dL | 30 |
| Bone metastases | 90 |
| Superscan pattern | 38 |
| Visceral metastases | |
| Lung | 3 |
| Liver | 5 |
| Brain | 1 |
| Local therapy to prostate | |
| Prostatectomy | 33 |
| Radiation therapy | 14 |
| No local therapy | 53 |
| Therapy for castration-resistant disease | |
| Chemotherapy | 37 |
| Abiraterone | 1 |
| Enzalutamide | 1 |
| 177Lu-PSMA-617 | 14 |
| Estimated median OS (mo) | 18 |
Data are reported as percentages of patients unless otherwise indicated.
ECOG = Eastern Cooperative Oncology Group.